by Katie Porter | Aug 30, 2017 | Events
It’s a Dutch Treat! The 3rd Annual Immunogenicity and Tolerance Seminar November 9th, 2017 [Updated] View Event Photos!...
by Katie Porter | Aug 22, 2017 | EpiVax Immunoncology, Featured, News, Thinking Out Loud -Blog
EpiVax has carved out a niche in the biotech and immunoinformatics industry with our innovative tools and discoveries. Well-situated on a trajectory Dr. De Groot described as “upward and stable,” EpiVax is now gearing up to launch a venture-backed spinoff called...
by Katie Porter | Aug 21, 2017 | Events
[Updated] View Event Photos! iCubed and EpiVax will be hosting a workshop in vaccine design and Computational Vaccinology, to be held at the Institut Pasteur in Paris, France on October 4th, 2017....
by Katie Porter | May 18, 2017 | Featured, News, Thinking Out Loud -Blog
Nineteen years ago, on May 18th, 1998, EpiVax incorporated as a biotechnology company. In 2017, our business has never been stronger: the team is stacked with talent, collaborations are abundant and world-wide, and our in silico user base is extensive. We were...
by Katie Porter | Apr 14, 2017 | Events, Featured
Those of us on the U.S. East Coast are happy to say farewell to winter – Spring is Here! And EpiVax is springing up everywhere! Join us at the following events to learn more about immunogenicity, influenza vaccines, personalized cancer vaccines and more!...
